IPO registrations (S-1, F-1) · Registrants

GENAISSANCE PHARMACEUTICALS INC

SEC CIK
1110009 · filings on EDGAR ↗
Registration
Form S-1, first filed 2000-04-20, last 2000-07-31; 1 initial registration, 4 amendments
Outcome
Final prospectus filed 2000-08-02
Industry (SIC)
Services-Commercial Physical & Biological Research 8731
Incorporated in
DE
Business address
FIVE SCIENCE PARK, New Haven, CT 06511
EIN
06-1338846
EDGAR entity type
operating

Offering terms

Proposed price range
$11.00–$13.00 per share (S-1/A filed 2000-07-31)
Final price
$13.00 per share, within the range (424B4 filed 2000-08-02, an initial public offering)
Shares sold
6,000,000
Gross proceeds
$78,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol GNSC
Lead underwriters
Deutsche Bank
Syndicate
Bear Stearns; Citigroup; UBS

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 6

FiledFormWhat it isName as filedEDGAR
2000-04-20S-1S-1 (registration)GENAISSANCE PHARMACEUTICALS INC0000912057-00-019052 ↗
2000-07-03S-1/AS-1/A (amendment)GENAISSANCE PHARMACEUTICALS INC0000912057-00-030756 ↗
2000-07-12S-1/AS-1/A (amendment)GENAISSANCE PHARMACEUTICALS INC0000912057-00-031687 ↗
2000-07-28S-1/AS-1/A (amendment)GENAISSANCE PHARMACEUTICALS INC0000912057-00-033655 ↗
2000-07-31S-1/AS-1/A (amendment)GENAISSANCE PHARMACEUTICALS INC0000912057-00-033775 ↗
2000-08-02424B4424B4 (final prospectus)GENAISSANCE PHARMACEUTICALS INC0000912057-00-034185 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2000-07-31S-1/Aregistration statement$11.00–$13.006,000,000-Nasdaq GNSC4primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 4document ↗
2000-08-02424B4final prospectus$13.006,000,000$78,000,000Nasdaq GNSC4primary document; price sentence, shares headline, proceeds computed, cover names 4document ↗

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationCOGENICS, INC.CTState business registriesEIN (EXACT, as the state registration reports it)
Lobbying clientGENAISSANCE PHARMACEUTICALSCTFederal lobbying (LDA)name and state

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Services-Commercial Physical & Biological Research, CT first:

More with this interest.

In other datasets, the same topic (Medical research) in CT:

Interests: Services-Commercial Physical & Biological Research · Medical research